Position in ACAD
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$3,783,176
-$281,097 QoQ
Shares Held
169,954
+11.7% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. ACAD ranks #27 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503,564 | $224,861,468 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,152 | $84,335,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
171,797 | $56,842,473 | |
| 4 | INSM |
INSMED Inc
|
299,925 | $49,043,736 | |
| 5 | ARGX |
Argenx SE
|
61,418 | $44,850,494 | |
| 6 | RPRX |
Royalty Pharma plc
|
495,892 | $23,787,939 | |
| 7 | GMAB |
Genmab A/S
|
862,301 | $23,135,535 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
678,518 | $18,794,948 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,783,176 | 169,954 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $4,064,273 | 152,163 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,193,424 | 149,645 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,508,187 | 162,642 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,369,698 | 142,667 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,957,284 | 106,664 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,825,621 | 118,701 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,747,573 | 107,543 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,952,155 | 105,579 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,725,680 | 150,932 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,580,624 | 171,815 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,215,782 | 92,517 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,217,578 | 64,696 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $867,480 | 54,490 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $960,364 | 58,702 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $891,192 | 63,250 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,724,124 | 71,186 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,811,814 | 77,627 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,702,574 | 102,503 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $2,558,340 | 104,893 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,615,604 | 101,380 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,170,613 | 21,897 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $769,188 | 18,647 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $773,775 | 15,964 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $669,409 | 15,844 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||